SARS-CoV-2 has affected more than 200 million people causing more than 5 million deaths worldwide as per the WHO statistics. The rise in mutant variants of SARS-CoV-2 virus has led to concerns regarding vaccine effectiveness. Delta (B.1.617.2) variant is the predominant strain in India. The vaccination programme in India is driven largely by the Covishield vaccine (ChAdOx1 nCoV-19).
- Read more about Effectiveness of COVISHIELD vaccine against the delta variant of SARS-CoV-2 in India
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/effectiveness-of-chadox1-ncov-19-covishield-vaccine-against-the-delta-variant-of-sars-cov-2-in-india
No comments:
Post a Comment